0001209191-19-033620.txt : 20190531 0001209191-19-033620.hdr.sgml : 20190531 20190531160543 ACCESSION NUMBER: 0001209191-19-033620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190531 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOUSE JACQUALYN A CENTRAL INDEX KEY: 0001405288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 19870460 MAIL ADDRESS: STREET 1: C/O DICK'S SPORTING GOODS STREET 2: 345 COURT STREET CITY: CORAOPOLIS STATE: PA ZIP: 15108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-31 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001405288 FOUSE JACQUALYN A C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 1 1 0 0 Chief Executive Officer Common stock 2019-05-31 4 M 0 1400 A 1400 D Restricted stock units 2019-05-31 4 M 0 1400 0.00 D Common stock 1400 0 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested. /s/ William Cook, as Attorney-in-fact for Jacqualyn Fouse 2019-05-31